naphthalimides has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baral, R; Goswami, KK; Mallick, A; Sanyal, U; Saxena, AK; Sen, A | 1 |
| Dutta, S; Pain, A; Pandita, RM; Qazi, GN; Samanta, S; Sanyal, U; Saxena, AK; Shanmugavel, M | 1 |
2 other study(ies) available for naphthalimides and Sarcoma 180
| Article | Year |
|---|---|
In vitro and in vivo evaluation of 2-chloroethylnitrosourea derivatives as antitumor agents.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; CD4 Antigens; CD8 Antigens; Cell Line, Tumor; Ethylnitrosourea; Humans; Interleukin-2 Receptor alpha Subunit; Kidney; Liver; Male; Mice; Naphthalimides; Neoplasms; Sarcoma 180 | 2015 |
Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Topics: Alkylation; Animals; Antineoplastic Agents; Cell Line, Tumor; DNA; DNA, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Imides; Isoquinolines; Lomustine; Mice; Naphthalenes; Naphthalimides; Neoplasm Transplantation; RNA, Neoplasm; Sarcoma 180; Thymidine; Uridine | 2005 |